Reclast Approved For Once Yearly Treatment Of Postmenopausal Osteoporosis
This article was originally published in The Pink Sheet Daily
Executive Summary
Zoledronic acid is the only osteoporosis therapy proven to reduce fractures across all key sites, Novartis claims.